Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Prepaid Assets (2016 - 2026)

Pharma-Bio Serv filings provide 16 years of Prepaid Assets readings, the most recent being $109108.0 for Q1 2026.

  • On a quarterly basis, Prepaid Assets fell 73.93% to $109108.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $109108.0, a 73.93% decrease, with the full-year FY2025 number at $171574.0, down 61.22% from a year prior.
  • Prepaid Assets hit $109108.0 in Q1 2026 for Pharma-Bio Serv, down from $171574.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $623540.0 in Q1 2022 to a low of $109108.0 in Q1 2026.
  • Median Prepaid Assets over the past 5 years was $442384.0 (2024), compared with a mean of $426332.3.
  • Biggest five-year swings in Prepaid Assets: soared 64.02% in 2022 and later plummeted 73.93% in 2026.
  • Pharma-Bio Serv's Prepaid Assets stood at $498374.0 in 2022, then fell by 3.08% to $483034.0 in 2023, then fell by 8.42% to $442384.0 in 2024, then plummeted by 61.22% to $171574.0 in 2025, then crashed by 36.41% to $109108.0 in 2026.
  • The last three reported values for Prepaid Assets were $109108.0 (Q1 2026), $171574.0 (Q4 2025), and $415093.0 (Q3 2025) per Business Quant data.